PTSD: Clinical Trials

3 trials for PTSD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 3

Follow PTSD: new trials by email Literature Review of PTSD trials Research Report on PTSD

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD
Psilocybin - Post Traumatic Stress Disorder, PTSD
Phase 2Active not recruitingUnity Health Toronto152026-06-012026-10-06
Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms
OTX-601 Digital Therapeutic, OTX-003 Comparator app - PTSD, Post Traumatic Stress Disorder
Phase 2Active not recruitingOui Therapeutics, Inc.402025-12-092026-07-15
PsiloStudy: Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)
Psilocybin 25 mg, Maltodextrin (Placebo) - Alcohol Use Disorder (AUD), PTSD
Phase 2Active not recruitingNathan Brashares Sackett402025-06-012026-08-13

Narrower conditions

Stress Disorders, Post-Traumatic (3)  ·  Alcoholism (1)

Broader conditions

Mental Disorders (3)  ·  Stress Disorders, Traumatic (3)  ·  Trauma and Stressor Related Disorders (3)  ·  Alcohol-Related Disorders (1)  ·  Chemically-Induced Disorders (1)  ·  Substance-Related Disorders (1)

Interventions

Psilocybin (2)  ·  maltodextrin (1)

Sponsors

Nathan Brashares Sackett (1)  ·  Oui Therapeutics, Inc. (1)  ·  Unity Health Toronto (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Nathan B Sackett, MD (1)

Results publications

PMID 39823496

NIH funding

R44MH136888 (1)